Remove Biotech Remove Marketing Remove Systems Review
article thumbnail

The Week’s 10 Biggest Funding Rounds: Crusoe Energy, Insider And Biotech Raise Big

Crunchbase News

startups raised half a billion dollars apiece, and another eight raised $100 million or more, with industries from cybersecurity to biotech to AI represented. tied) Crusoe Energy Systems , $500M, energy: This is not the first time Crusoe has made this list. billion valuation in the process. Founded in 2018, the company has raised $1.2

Biotech 128
article thumbnail

6 investors discuss why AI is more than just a buzzword in biotech

TechCrunch

That’s why we weren’t very surprised when a slew of investors told us they rarely see a biotech startup that doesn’t incorporate AI in some form or other these days. But despite becoming quite the buzzword, AI’s apparent ubiquity in biotech isn’t actually driving deal flow or higher valuations.

Biotech 242
article thumbnail

Forecast: 13 Companies That Could Go Public In 2025 If The IPO Market Gains Steam

Crunchbase News

Although 2024 was another exceptionally lackluster year for new public offerings, the IPO market could gain momentum in 2025 after its three-year lull. With that in mind, here are 13 companies that the Crunchbase News team thinks could be top contenders to go public if our 2025 market forecast bears out. That made sense.

Marketing 128
article thumbnail

This VC built a lab to make building biotech startups easier

TechCrunch

When you think of life sciences and biotech hubs in the U.S., Portal Innovations , a biotech VC firm based in Chicago, is trying to broaden everyone’s horizons and give opportunities to biotech startups growing out of labs in Chicago, Atlanta, and hopefully beyond. As AI pervades biotech, what are investors looking for in 2023?

Biotech 203
article thumbnail

Psychedelics startups are on a long journey to consumer markets, but these 5 VCs are taking the ride

TechCrunch

.” A more favorable regulatory and social landscape is helping psychedelic startups gain a foothold, but they still have to walk a tightrope that’s susceptible to the vagaries of market sentiment. But as public market sentiment fluctuates, specialized VCs seem more likely to stick around for the whole trip. Ready for the trip?

Marketing 235
article thumbnail

Glyphic Biotechnologies raises $6M to accelerate protein sequencing by orders of magnitude

TechCrunch

The whole human proteome may be free to browse thanks to DeepMind , but at the bleeding edge of biotech new proteins are made and tested every day, a complex and time-consuming process. If everything works as advertised, Glyphic could be the new standard in protein sequencing just as demand skyrockets in the biotech world.

Biotech 249
article thumbnail

Holmes’ sentencing sends a clear message that the startup ecosystem must be built on good faith

TechCrunch

Sure, due diligence matters in the investment process, but lying about your capabilities can undercut the founder-investor relationship — and in extreme cases, to the detriment of the larger, global startup market.